A Day Up For CymaBay Therapeutics, Inc.
Tue 12 May 20 at 05:30 PM
CymaBay Therapeutics, Inc. (CBAY:NASDAQ) soared at $4.18, a gain of 127.2%. On Mon 11 May 20, CBAY:NASDAQ hit a New 2-Week Intraday High of $1.88. The stock appeared on our News Catalysts scanner on Mon 04 May 20 at 06:57 PM in the 'EARNINGS' category. From Mon 27 Apr 20, the stock recorded 60.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About CymaBay Therapeutics, Inc. (CBAY:NASDAQ)
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.
Top 10 Gainers:
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 127.17%
- Novavax, Inc. (NVAX:NASDAQ), 62.53%
- Rand Capital Corporation (RAND:NASDAQ), 43.07%
- Super League Gaming, Inc. (SLGG:NASDAQ), 41.3%
- Babcock & Wilcox Enterprises, Inc. (BW:NYSE), 40.26%
- Gamida Cell Ltd. (GMDA:NASDAQ), 36.56%
- Naked Brand Group Limited (NAKD:NASDAQ), 34.62%
- VectoIQ Acquisition Corp. (VTIQ:NASDAQ), 32.97%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 32.33%
- Grubhub Inc. (GRUB:NYSE), 29.07%